-+ 0.00%
-+ 0.00%
-+ 0.00%

Raymond James Initiates Coverage On Polaryx Therapeutics with Strong Buy Rating, Announces Price Target of $6

Benzinga·08/13/2026 10:32:55
Listen to the news
Raymond James analyst Tiago Fauth initiates coverage on Polaryx Therapeutics (NASDAQ:PLYX) with a Strong Buy rating and announces Price Target of $6.